Hao Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hao Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Yongquan Chen
Department of Anesthesiology, The First Affiliated Hospital of Wannan Medical University, Yijishan Hospital, Wuhu, China
2 shared publications - Bin Wang
Department of Anesthesiology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, China
1 shared publication - Can Liu
The First Affiliated Hospital of Wannan Medical College
1 shared publication Chu-Chu Du
Department of Anesthesiology, the First Affiliated Hospital of Wannan Medical College, Wuhu, China
1 shared publication- Liangbin Cao
Department of Anesthesiology, Yijishan Hospital, First Affiliated Hospital of Wannan Medical College, Wuhu, China
1 shared publication - Ling Guo
Department of Anesthesiology, the First Affiliated Hospital of Wannan Medical College, Wuhu, China
1 shared publication
Latest Publications
- Open Access
- 12 February 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Fluid responsiveness-guided individualized strategy for preventing hypotension after spinal anesthesia in cesarean delivery: a randomized trial of prehydration versus norepinephrine preinfusion
Objective: This study aimed to evaluate the efficacy of fluid responsiveness-guided strategies for preventing spinal anesthesia-induced hypotension (SAIH) in parturients undergoing cesarean delivery, comparing prophylactic fluid loading with norepinephrine infusion. Methods: In this fluid responsiveness-based stratified randomized controlled trial, eligible parturients were stratified into fluid responsive (FR(+)) and non-fluid responsive (FR(-)) cohorts according to carotid corrected flow time (FTc). Each stratum had a preset sample size of 236, and within each stratum, participants were randomly assigned to receive either prophylactic colloid infusion (Co) or norepinephrine infusion (NE), ultimately forming four subgroups: FR(+)/Co, FR(+)/NE, FR(-)/Co, and FR(-)/NE.Primary outcomes included the incidence of SAIH and maximum reduction in mean arterial pressure (MAP). Secondary outcomes encompassed neonatal umbilical cord blood gas analysis, Apgar scores, intraoperative hemodynamic changes, and postoperative recovery parameters. Results: Among fluid-responsive parturients, prophylactic fluid loading (FR(+)/Co) and norepinephrine infusion (FR(+)/NE) demonstrated comparable efficacy in preventing SAIH (16.7% vs. 15.1%, P > 0.05). In contrast, non-fluid-responsive parturients receiving fluid loading (FR(-)/Co) had a significantly higher SAIH incidence (34.2%) compared to those receiving norepinephrine (FR(-)/NE, 13.6%, P = 0.0004). Neonatal umbilical cord blood lactate levels were higher in the FR(+)/NE group compared to the FR(+)/Co group (1.66 ± 0.25 mmol/L vs. 1.55 ± 0.28 mmol/L, P = 0.006), suggesting potential fetal hypoxia. Additionally, the FR(+)/NE group exhibited prolonged postoperative gastrointestinal recovery times compared to the FR(+)/Co group (29 [20, 39] h vs. 24 [16, 35] h, P = 0.0438). Conclusion: Fluid loading is optimal for fluid-responsive parturients, whereas norepinephrine infusion is superior for non-fluid-responsive parturients. These findings advocate for fluid responsiveness-guided individualized SAIH prevention strategies to optimize maternal and neonatal outcomes. Trial registration: This trial was prospectively registered at ClinicalTrials.gov (ChiCTR2400084392) on May 15, 2024, prior to participant enrollment.
- 12 February 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessFluid responsiveness-guided individualized strategy for preventing hypotension after spinal anesthesia in cesarean delivery: a randomized trial of prehydration versus norepinephrine preinfusion
Objective: This study aimed to evaluate the efficacy of fluid responsiveness-guided strategies for preventing spinal anesthesia-induced hypotension (SAIH) in parturients undergoing cesarean delivery, comparing prophylactic fluid loading with norepinephrine infusion. Methods: In this fluid responsiveness-based stratified randomized controlled trial, eligible parturients were stratified into fluid responsive (FR(+)) and non-fluid responsive (FR(-)) cohorts according to carotid corrected flow time (FTc). Each stratum had a preset sample size of 236, and within each stratum, participants were randomly assigned to receive either prophylactic colloid infusion (Co) or norepinephrine infusion (NE), ultimately forming four subgroups: FR(+)/Co, FR(+)/NE, FR(-)/Co, and FR(-)/NE.Primary outcomes included the incidence of SAIH and maximum reduction in mean arterial pressure (MAP). Secondary outcomes encompassed neonatal umbilical cord blood gas analysis, Apgar scores, intraoperative hemodynamic changes, and postoperative recovery parameters. Results: Among fluid-responsive parturients, prophylactic fluid loading (FR(+)/Co) and norepinephrine infusion (FR(+)/NE) demonstrated comparable efficacy in preventing SAIH (16.7% vs. 15.1%, P > 0.05). In contrast, non-fluid-responsive parturients receiving fluid loading (FR(-)/Co) had a significantly higher SAIH incidence (34.2%) compared to those receiving norepinephrine (FR(-)/NE, 13.6%, P = 0.0004). Neonatal umbilical cord blood lactate levels were higher in the FR(+)/NE group compared to the FR(+)/Co group (1.66 ± 0.25 mmol/L vs. 1.55 ± 0.28 mmol/L, P = 0.006), suggesting potential fetal hypoxia. Additionally, the FR(+)/NE group exhibited prolonged postoperative gastrointestinal recovery times compared to the FR(+)/Co group (29 [20, 39] h vs. 24 [16, 35] h, P = 0.0438). Conclusion: Fluid loading is optimal for fluid-responsive parturients, whereas norepinephrine infusion is superior for non-fluid-responsive parturients. These findings advocate for fluid responsiveness-guided individualized SAIH prevention strategies to optimize maternal and neonatal outcomes. Trial registration: This trial was prospectively registered at ClinicalTrials.gov (ChiCTR2400084392) on May 15, 2024, prior to participant enrollment.
- Open Access
- 3 January 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (5) , 6228-6255
Identifying Pyroptosis-Hub Genes and Inflammation Cell Type-Related Genes in Ischemic Stroke
Stroke is the second-leading global cause of death. The damage attributed to the immune storm triggered by ischemia–reperfusion injury (IRI) post-stroke is substantial. However, data on the transcriptomic dynamics of pyroptosis in IRI are limited. This study aimed to analyze the expression of key pyroptosis genes in stroke and their correlation with immune infiltration. Pyroptosis-related genes were identified from the obtained middle cerebral artery occlusion (MCAO) datasets. Differential expression and functional analyses of pyroptosis-related genes were performed, and differences in functional enrichment between high-risk and low-risk groups were determined. An MCAO diagnostic model was constructed and validated using selected pyroptosis-related genes with differential expression. High- and low-risk MCAO groups were constructed for expression and immune cell correlation analysis with pyroptosis-related hub genes. A regulatory network between pyroptosis-related hub genes and miRNA was also constructed, and protein domains were predicted. The expression of key pyroptosis genes was validated using an MCAO rat model. Twenty-five pyroptosis genes showed differential expression, including four hub genes, namely WISP2, MELK, SDF2L1, and AURKB. Characteristic genes were verified using real-time quantitative PCR analyses. The high- and low-risk groups showed significant expression differences for WISP2, MELK, and SDF2L1. In immune infiltration analysis, 12 immune cells showed differences in expression in MCAO samples. Further analysis demonstrated significant positive correlations between the pyroptosis-related hub gene SDF2L1 and immune cell-activated dendritic cells in the high-risk group and immune cell natural killer cells in the low-risk group. This study identified four pyroptosis-related hub genes, with elevated WISP2, MELK, and SDF2L1 expression closely associated with the high-risk group. The analysis of inflammatory cell types in immune infiltration can predict ischemic stroke risk levels and help to facilitate treatment.
- 3 January 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (5) , 6228-6255
Open AccessIdentifying Pyroptosis-Hub Genes and Inflammation Cell Type-Related Genes in Ischemic Stroke
Stroke is the second-leading global cause of death. The damage attributed to the immune storm triggered by ischemia–reperfusion injury (IRI) post-stroke is substantial. However, data on the transcriptomic dynamics of pyroptosis in IRI are limited. This study aimed to analyze the expression of key pyroptosis genes in stroke and their correlation with immune infiltration. Pyroptosis-related genes were identified from the obtained middle cerebral artery occlusion (MCAO) datasets. Differential expression and functional analyses of pyroptosis-related genes were performed, and differences in functional enrichment between high-risk and low-risk groups were determined. An MCAO diagnostic model was constructed and validated using selected pyroptosis-related genes with differential expression. High- and low-risk MCAO groups were constructed for expression and immune cell correlation analysis with pyroptosis-related hub genes. A regulatory network between pyroptosis-related hub genes and miRNA was also constructed, and protein domains were predicted. The expression of key pyroptosis genes was validated using an MCAO rat model. Twenty-five pyroptosis genes showed differential expression, including four hub genes, namely WISP2, MELK, SDF2L1, and AURKB. Characteristic genes were verified using real-time quantitative PCR analyses. The high- and low-risk groups showed significant expression differences for WISP2, MELK, and SDF2L1. In immune infiltration analysis, 12 immune cells showed differences in expression in MCAO samples. Further analysis demonstrated significant positive correlations between the pyroptosis-related hub gene SDF2L1 and immune cell-activated dendritic cells in the high-risk group and immune cell natural killer cells in the low-risk group. This study identified four pyroptosis-related hub genes, with elevated WISP2, MELK, and SDF2L1 expression closely associated with the high-risk group. The analysis of inflammatory cell types in immune infiltration can predict ischemic stroke risk levels and help to facilitate treatment.